Company CVAbout Zenotech Laboratories Ltd 
Zenotech Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Zenotech Laboratories Limited (Formerly Sunline Technologies Limited) was established in June, 1989 and changed to its present name effective on August 9, 2004. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology.
Company Coordinates
Company Details
S No 250-252 Turkapally Villag, Shameerpet Mandal RR District Hyderabad Telangana : 500078
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 61.03 Cr
Number of Shares
6.1 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
01-Jun-2017
6.1
61.03
26603068
10
Right Issues
01-Jun-2017
6.1
61.03
26603068
10
Right Issues
06-Aug-2010
3.44
34.43
2500
10
ESOP
06-Aug-2010
3.44
34.43
2500
10
ESOP
30-Jun-2008
3.44
34.42
25000
10
ESOP
30-Jun-2008
3.44
34.42
25000
10
ESOP
29-Jun-2008
3.44
34.40
50000
10
ESOP
29-Jun-2008
3.44
34.40
50000
10
ESOP
30-Jan-2008
3.44
34.35
50000
10
ESOP
30-Jan-2008
3.44
34.35
50000
10
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Sun Pharmaceutical Industries Limited (68.84%)
Highest Public shareholder
Padmasree Chigurupati (5.26%)
Individual Investors Holdings
22.83%
Board of Directors
Management
Designation
Remuneration
Kavita Shah
Independent Director
75.0 k
Jignesh Anantray Goradia
Non Executive Director
75.0 k
Azadar Hussain Khan
Non Executive Director
0
Chintan Jitendra Shah
Independent Director
60.0 k
Abdul Gafoor Mohammad
Company Sec. & Compli. Officer
0
JAGRUTI PRASHANT SHETH
Independent Director
75.0 k
Rakeshchandra Jagdishprasad Sinha
Non Executive Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Lease Rental Income
0.13
0.00%
Oncology Products
0.76
0.00%
Service Income - Contract Manufacturing
12.27
0.00%
Lease Rental Income
Oncology Products
Service Income - Contract Manufacturing
Stock DNARevenue and Profits:
Net Sales:
10 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
Pharmaceuticals & Drugs
INR 388 Cr (Micro Cap)
93.00
33
0.00%
-0.24
4.16%
3.88
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
